The Bronchoscopy Market was valued at USD 3.3 billion in 2024, and is projected to reach USD 6.8 billion by 2034, rising at a CAGR of 7.2%. The increasing prevalence of respiratory diseases, including tuberculosis, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD), is driving demand for bronchoscopy procedures. Advancements in medical technology, such as robot-assisted bronchoscopies and AI-powered imaging, are improving diagnostic accuracy and procedural efficiency. The rising preference for minimally invasive techniques is further boosting market expansion.
The industry is categorized by product type into rigid bronchoscopes, flexible bronchoscopes, and other related products. Flexible bronchoscopes held the largest market share of 57.1% in 2024 and are anticipated to grow at a CAGR of 7.4% throughout the forecast period. The incorporation of high-definition video, artificial intelligence, and narrow-band imaging (NBI) has significantly improved the visualization of the lungs and airways, enabling real-time diagnostics and advanced image processing. These enhancements are increasing the efficiency of procedures and improving patient outcomes.
Based on usage, the market is segmented into single-use/disposable and reusable bronchoscopes. In 2024, the single-use/disposable segment dominated with a 56.3% share. The industry is witnessing a notable shift from traditional open surgical techniques to minimally invasive approaches, increasing the demand for disposable bronchoscopes. Concerns over hospital-acquired infections (HAIs) are further accelerating the adoption of single-use instruments, as they reduce cross-contamination risks and ensure a higher level of patient safety. The growing emphasis on infection prevention protocols in healthcare settings is expected to sustain the demand for disposable bronchoscopes.
US bronchoscopy market was valued at USD 921.1 million in 2023, maintaining a strong position within the global industry. The rising incidence of lung cancer is expected to drive procedural demand, with healthcare providers increasing their reliance on bronchoscopy for early diagnosis and treatment planning. The presence of key industry players and continuous advancements in bronchoscopy technology are reinforcing the country’s leadership in the global market. As demand for precise, minimally invasive procedures continues to rise, the bronchoscopy market is poised for steady growth in the years ahead.
This product will be delivered within 2-4 business days.
The industry is categorized by product type into rigid bronchoscopes, flexible bronchoscopes, and other related products. Flexible bronchoscopes held the largest market share of 57.1% in 2024 and are anticipated to grow at a CAGR of 7.4% throughout the forecast period. The incorporation of high-definition video, artificial intelligence, and narrow-band imaging (NBI) has significantly improved the visualization of the lungs and airways, enabling real-time diagnostics and advanced image processing. These enhancements are increasing the efficiency of procedures and improving patient outcomes.
Based on usage, the market is segmented into single-use/disposable and reusable bronchoscopes. In 2024, the single-use/disposable segment dominated with a 56.3% share. The industry is witnessing a notable shift from traditional open surgical techniques to minimally invasive approaches, increasing the demand for disposable bronchoscopes. Concerns over hospital-acquired infections (HAIs) are further accelerating the adoption of single-use instruments, as they reduce cross-contamination risks and ensure a higher level of patient safety. The growing emphasis on infection prevention protocols in healthcare settings is expected to sustain the demand for disposable bronchoscopes.
US bronchoscopy market was valued at USD 921.1 million in 2023, maintaining a strong position within the global industry. The rising incidence of lung cancer is expected to drive procedural demand, with healthcare providers increasing their reliance on bronchoscopy for early diagnosis and treatment planning. The presence of key industry players and continuous advancements in bronchoscopy technology are reinforcing the country’s leadership in the global market. As demand for precise, minimally invasive procedures continues to rise, the bronchoscopy market is poised for steady growth in the years ahead.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Product Usage, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Age Group, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies featured in this Bronchoscopy market report include:- Ambu
- Boston Scientific Corporation
- Broncus Medical
- Cogentix Medical
- CONMED Corporation
- Cook Medical
- FUJIFILM Holdings America Corporation
- Hoya Corporation
- Johnson & Johnson
- Karl Storz
- Medtronic
- Olympus Corporation
- Richard Wolf
- Teleflex
- Verathon
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | February 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 3.3 Billion |
| Forecasted Market Value ( USD | $ 6.8 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
